Trends in the susceptibility of methicillin-resistant Staphylococcus aureus to nine antimicrobial agents, including ceftobiprole, nemonoxacin, and tyrothricin: Results from the Tigecycline in Vitro Surveillance in Taiwan (TIST) study, 2006-2010

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 2, 2014, Pages 233-239

  Chen, Y H ^a   Liu, C Y ^b   Ko, W C ^c   Liao, C H ^b   Lu, P L ^a   Huang, C H ^d   Lu, C T ^e   Chuang, Y C ^f   Tsao, S M ^g   Chen, Y S ^h,i   Liu, Y C ^h,i   Chen, W Y ^j   Jang, T N ^j   Lin, H C ^k   Chen, C M ^l   Shi, Z Y ^m   Pan, S C ⁿ   Yang, J L ⁿ   Kung, H C ⁿ   Liu, C E ^o   Cheng, Y J ^o   Liu, J W ^p   Sun, W ^q   Wang, L S ^r   Yu, K W ^s   Chiang, P C ^t   Lee, M H ^t   Lee, C M ^u   Hsu, G J ^v   Hsueh, P R ⁿ   more..

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d CATHAY GENERAL HOSPITAL   (Taiwan)

^e LOTUNG POH AI HOSPITAL   (Taiwan)

^f CHI MEI MEDICAL CENTER   (Taiwan)

^g CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY   (Taiwan)

ⁱ KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^j SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^k TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^l TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

^m TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

ⁿ NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^o CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^p CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^q Pao Chien Hospital   (Taiwan)

^r BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^s TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^t Chang Gung Medical Foundation LinKou Branch   (Taiwan)

^u MACKAY MEMORIAL HOSPITAL   (Taiwan)

^v CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; EPIDEMIOLOGICAL MONITORING; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; QUINOLONES; STAPHYLOCOCCAL INFECTIONS; TAIWAN; TYROTHRICIN;

EID: 84893980419     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1949-y     Document Type: Review

References (38)

1. Tong SY, Chen LF, Fowler VG Jr (2012) Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance? Semin Immunopathol 34:185-200
2. Jean SS, Hsueh PR (2011) High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents 37:291-295
3. Stefani S, Chung DR, Lindsay JA, Friedrich AW, Kearns AM, Westh H, Mackenzie FM (2012) Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents 39:273-282
4. Tseng SH, Lee CM, Lin TY, Chang SC, Chang FY (2011) Emergence and spread of multi-drug resistant organisms: think globally and act locally. J Microbiol Immunol Infect 44:157-165
5. Calfee DP (2012) Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare. Curr Opin Infect Dis 25:385-394
6. Huang YT, Liao CH, Teng LJ, Hsueh PR (2008) Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan. Clin Microbiol Infect 14:124-129
7. Gupta A, Biyani M, Khaira A (2011) Vancomycin nephrotoxicity: myths and facts. Neth J Med 69:379-383
8. Schilling A, Neuner E, Rehm SJ (2011) Vancomycin: a 50-something-year-old antibiotic we still don't understand. Cleve Clin J Med 78:465-471
9. Chen YH, Lu PL, Huang CH, Liao CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Liu JW, Sun W, Wang LS, Ko WC, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Hsueh PR (2012) Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010. Antimicrob Agents Chemother 56:1452-1457
10. Hsueh PR (2008) Tigecycline In-vitro Surveillance in Taiwan (TIST). Int J Antimicrob Agents 32(Suppl 3):S173
11. Tsai HY, Liao CH, Chen YH, Lu PL, Huang CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Liu JW, Sun W, Wang LS, Ko WC, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Hsueh PR (2012) Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010. Antimicrob Agents Chemother 56:3402-3405
12. Clinical and Laboratory Standards Institute (CLSI) (2013) Performance standards for antimicrobial susceptibility testing; Twenty-third informational supplement. CLSI document M100-S23. CLSI, Wayne
13. Liao CH, Lai CC, Chen SY, Huang YT, Hsueh PR (2010) Strain relatedness of meticillin-resistant Staphylococcus aureus isolates recovered from patients with repeated bacteraemia. Clin Microbiol Infect 16:463-469
14. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233-2239
15. Kullar R, Davis SL, Kaye KS, Levine DP, Pogue JM, Rybak MJ (2013) Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia. Pharmacotherapy 33:3-10
16. Kullar R, Davis SL, Levine DP, Rybak MJ (2011) Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis 52:975-981
17. Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J (2008) Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 46:193-200
18. Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chen WJ, Chang SC, Hsueh PR (2012) Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration. Clin Infect Dis 55:1329-1337
19. Lin SY, Chen TC, Chen FJ, Chen YH, Lin YI, Siu LK, Lu PL (2012) Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan medical center. J Microbiol Immunol Infect 45:435-441
20. Noel GJ, Bush K, Bagchi P, Ianus J, Strauss RS (2008) A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Clin Infect Dis 46:647-655
21. Fritsche TR, Sader HS, Jones RN (2008) Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006). Diagn Microbiol Infect Dis 61:86-95
22. Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM (2013) The emerging problem of linezolid-resistant Staphylococcus. J Antimicrob Chemother 68:4-11
23. Sader HS, Moet GJ, Farrell DJ, Jones RN (2011) Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010). Diagn Microbiol Infect Dis 70:412-416
24. Keel RA, Sutherland CA, Aslanzadeh J, Nicolau DP, Kuti JL (2010) Correlation between vancomycin and daptomycin MIC values for methicillin-susceptible and methicillin-resistant Staphylococcus aureus by 3 testing methodologies. Diagn Microbiol Infect Dis 68:326-329
25. Patel N, Lubanski P, Ferro S, Bonafede M, Harrington S, Evans A, Stellrecht K, Lodise TP (2009) Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53:5141-5144
26. Diekema DI, Jones RN (2000) Oxazolidinones: a review. Drugs 59:7-16
27. Prasad P, Sun J, Danner RL, Natanson C (2012) Excess deaths associated with tigecycline after approval based on noninferiority trials. Clin Infect Dis 54:1699-1709
28. Alaniz C, Pogue JM (2012) Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial. Ann Pharmacother 46:1432-1435
29. Stryjewski ME, Chambers HF (2008) Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46(Suppl 5):S368-S377
30. Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR (2009) In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan. J Antimicrob Chemother 64:1226-1229
31. Mongkolrattanothai K, Mankin P, Raju V, Gray B (2008) Surveillance for mupirocin resistance among methicillin-resistant Staphylococcus aureus clinical isolates. Infect Control Hosp Epidemiol 29:993-994
32. Patel JB, Gorwitz RJ, Jernigan JA (2009) Mupirocin resistance. Clin Infect Dis 49:935-941
33. O'Shea S, Cotter L, Creagh S, Lydon S, Lucey B (2009) Mupirocin resistance among staphylococci: trends in the southern region of Ireland. J Antimicrob Chemother 64:649-650
34. Kresken M, Hafner D, Schmitz FJ, Wichelhaus TA; Paul-Ehrlich-Society for Chemotherapy (2004) Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001. Int J Antimicrob Agents 23:577-581
35. Jones JC, Rogers TJ, Brookmeyer P, Dunne WM Jr, Storch GA, Coopersmith CM, Fraser VJ, Warren DK (2007) Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 45:541-547
36. Korting HC, Schöllmann C, Stauss-Grabo M, Schäfer-Korting M (2012) Antimicrobial peptides and skin: a paradigm of translational medicine. Skin Pharmacol Physiol 25:323-334
37. Matula C, Nahler G, Kreuzig F (1988) Salivary levels of gramicidin after use of a tyrothricin-containing gargle/mouth-wash and tyrothricin lozenges. Int J Clin Pharmacol Res 8:259-261
38. Wigger-Alberti W, Stauss-Grabo M, Grigo K, Atiye S, Williams R, Korting HC (2013) Efficacy of a tyrothricin-containing wound gel in an abrasive wound model for superficial wounds. Skin Pharmacol Physiol 26:52-56